25.7 USD
+0.05 (+0.19%)
We assign a fundamental rating of 3 out of 10 to CHSCL. CHSCL was compared to 87 industry peers in the Food Products industry. CHSCL has a bad profitability rating. Also its financial health evaluation is rather negative. CHSCL is valued expensive and it does not seem to be growing. CHSCL also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- In the past year CHSCL had a positive cash flow from operations.
- In the past 5 years CHSCL has always been profitable.
- CHSCL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- CHSCL has a Return On Assets of 3.17%. This is comparable to the rest of the industry: CHSCL outperforms 59.77% of its industry peers.
- The Return On Equity of CHSCL (5.40%) is comparable to the rest of the industry.
- CHSCL has a Return On Invested Capital of 0.49%. This is in the lower half of the industry: CHSCL underperforms 60.92% of its industry peers.
- CHSCL had an Average Return On Invested Capital over the past 3 years of 3.89%. This is significantly below the industry average of 27.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROIC | 0.49% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
- CHSCL has a Profit Margin (1.69%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of CHSCL has grown nicely.
- The Operating Margin of CHSCL (0.26%) is worse than 62.07% of its industry peers.
- In the last couple of years the Operating Margin of CHSCL has declined.
- With a Gross Margin value of 3.21%, CHSCL is not doing good in the industry: 85.06% of the companies in the same industry are doing better.
- CHSCL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHSCL is destroying value.
- Compared to 1 year ago, CHSCL has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.32 indicates that CHSCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of CHSCL (2.32) is comparable to the rest of the industry.
- CHSCL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
- CHSCL has a Debt to Equity ratio of 0.26. This is in the better half of the industry: CHSCL outperforms 64.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.32 |
ROIC/WACC0.09
WACC5.46%
2.3 Liquidity
- CHSCL has a Current Ratio of 1.53. This is a normal value and indicates that CHSCL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.53, CHSCL is in line with its industry, outperforming 48.28% of the companies in the same industry.
- A Quick Ratio of 0.91 indicates that CHSCL may have some problems paying its short term obligations.
- CHSCL has a Quick ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- CHSCL shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.
- Measured over the past years, CHSCL shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCL indicates a rather cheap valuation: CHSCL is cheaper than 95.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.46 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CHSCL has a Yearly Dividend Yield of 7.18%, which is a nice return.
- Compared to an average industry Dividend Yield of 2.46, CHSCL pays a better dividend. On top of this CHSCL pays more dividend than 91.95% of the companies listed in the same industry.
- CHSCL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.18% |
5.2 History
- CHSCL has been paying a dividend for at least 10 years, so it has a reliable track record.
- As CHSCL did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years9
5.3 Sustainability
- CHSCL pays out 28.20% of its income as dividend. This is a sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCL (1/14/2026, 1:43:25 PM)
25.7
+0.05 (+0.19%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06 2026-01-06
Earnings (Next)03-31 2026-03-31
Inst Owners11.23%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap315.34M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.18% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.5 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.46 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY201.62%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROCE | 0.67% | ||
| ROIC | 0.49% | ||
| ROICexc | 0.5% | ||
| ROICexgc | 0.5% | ||
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.9 | ||
| Cap/Depr | 111.84% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 85.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.46%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 7 1/2 PERP / CHSCL FAQ
What is the fundamental rating for CHSCL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCL.
Can you provide the valuation status for CHS INC - CHSINC 7 1/2 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7 1/2 PERP (CHSCL). This can be considered as Overvalued.
What is the profitability of CHSCL stock?
CHS INC - CHSINC 7 1/2 PERP (CHSCL) has a profitability rating of 3 / 10.
How sustainable is the dividend of CHS INC - CHSINC 7 1/2 PERP (CHSCL) stock?
The dividend rating of CHS INC - CHSINC 7 1/2 PERP (CHSCL) is 7 / 10 and the dividend payout ratio is 28.2%.